Managing myopia progression results in long-term savings

Serge Resnikoff, MD, PhD, chair of the International Myopia Institute, discussed the cost of early management of myopia progression at the FLORetina meeting. He dispelled misconceptions about the high cost,…

admin admin

Colorado board leaves Vertex drug off a list of unaffordable medicines

A Colorado state board voted not to place Vertex Pharmaceuticals' cystic fibrosis medication on a list of drugs for which payment limits will be set for most residents. The board…

admin admin

New Zealand reverses landmark tobacco controls

The new government of New Zealand (Aotearoa) plans to abandon tobacco control measures, prompting condemnation from the Māori health organization Hāpai Te Hauora. These measures include raising the legal age…

admin admin

Stretchable E-Skin for Robotic Prostheses

Researchers at the University of British Columbia have developed a highly sensitive e-skin for robotic prostheses in collaboration with the automotive company Honda. This technology allows robotic hands to perform…

admin admin

US approves sickle cell breakthrough with gene editing therapy

The United States has approved breakthrough gene editing therapy using the CRISPR tool to treat sickle cell disease. This is a major advancement in gene therapy for patients with sickle…

admin admin

£1.9 million funding supports research on drivers of health disparities and infection risk across England

Dr Rosalind Eggo, an Associate Professor at LSHTM, has been awarded over £1.9 million in funding to research health disparities and associated infectious disease burden across England. Health disparities are…

admin admin

Are No-Spray Christmas Trees Better for You? What to Know

The article discusses the benefits and popularity of no-spray, pesticide-free Christmas trees among environmentally concerned customers. It highlights the success of Reed Island Christmas Tree Farm in southern Virginia, which…

admin admin

FDA OKs Two Gene-Editing Therapies for Sickle Cell Disease

The FDA approved two gene-editing treatments for patients aged 12 years or older with severe sickle cell disease, marking the first cell-based gene therapies for the condition. Exa-cel uses CRISPR…

admin admin

Flaxseeds For Breast Cancer? Study Says Manipulating Gut Microbiota Using Them Could Reduce Risk

Researchers conducted a study on the manipulation of gut microbiota using flaxseeds and found that it could be beneficial in the prevention of breast cancer. Flaxseed is known for various…

admin admin
error: Content is protected !!